Cargando…
Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?
BACKGROUND/AIM: Pulmonary embolism (PE) is associated with high morbidity and mortality rates if not diagnosed and treated rapidly. The aim of our study was to investigate the relationship between levels of hypoxia-induced factor-1 alpha (HIF-1α) and clinical course and prognosis in patients with in...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379473/ https://www.ncbi.nlm.nih.gov/pubmed/32421278 http://dx.doi.org/10.3906/sag-1908-93 |